EHSI: Scientists Grow Intestine Using Stem Cells

Emerging Healthcare Solutions (PinkSheets:EHSI) was encouraged by the latest breakthrough in stem cell research this week when scientists at Cincinnati Children's Hospital Medical Center announced that they’ve grown functioning human intestinal tissue from stem cells for the first time.

The new intestinal tissue created in the lab absorbed nutrients and secreted the chemicals that help the intestine digest and metabolize food as well protect itself from bacteria—essentially performing all of the functions of a healthy human intestine. The astonishing achievement could pave the way to growing new intestinal tissue for transplantation into patients. The findings were published online Sunday in the journal Nature.

The laboratory growth of functional human intestinal tissue from induced pluripotent cells is only the latest in a string of medical breakthroughs involving stem cells. Earlier this week, doctors in Germany announced the discovery of a potential cure for AIDS using HIV-resistant stem cells to replace infected blood cells.

“Medical breakthroughs that once seemed like science fiction are becoming almost routine thanks to stem cell research,” said EHSI President and CEO Cindy Morrissey. “It’s a very exciting time to be involved with stem cells, because every new breakthrough increases demand for stem cell therapies across the globe.”

Emerging Healthcare Solutions is taking a worldwide approach to developing new stem cell treatments. Earlier this month, EHSI acquired Celulas Genetica, a Central American leader in stem-cell technology acquisition and development. In November, Morrissey established EHSI business offices in Frankfurt, Germany, and Warsaw, Poland. Those offices will allow the company to maintain long-term relationships with some of the world’s foremost stem-cell researchers and entrepreneurs based in Central and Western Europe.

EHSI invests in technology developed to compete in the stem-cell research industry alongside Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), Allergan, Inc. (NYSE:AGN), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Forest Laboratories, Inc. (NYSE:FRX).

About Emerging Healthcare Solutions, Inc.

Emerging Healthcare Solutions, Inc. invests in and participates in the profits of emerging breakthrough medical technologies. The Company believes the secret of leveraging future value for its shareholders is the proper timing of its investment in promising new medical technologies. EHSI aims to capture future profits of promising new medical technologies by investing in these technologies at the inflection point of product development. We believe this model will deliver long-term positive results for our investors.

For more information, please visit http://www.EmergingHealthcareSolutionsInc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.